Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
ID: 357912Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357912
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Academic Career Excellence (ACE) Award (K32), which requires an independent clinical trial. This grant aims to support late-stage graduate students and early-stage postdoctoral scholars in cancer research, specifically targeting those within 12 months of transitioning to their postdoctoral position or within the first two years of their postdoctoral training. The ACE Award is designed to enhance the scientific research and career development experience of applicants, who must have a well-defined research and training plan in collaboration with a postdoctoral research group. The anticipated first due date for applications is June 12, 2025, with an estimated award date of March 2, 2026. For further inquiries, interested applicants should refer to the NIH's official communications as the opportunity progresses.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming Academic Career Excellence (ACE) Award (K32), aimed at providing funding support for late-stage graduate students and early-stage postdoctoral scholars in cancer research. This grant opportunity is designed to enhance the scientific research and career development experience of candidates transitioning to postdoctoral positions, requiring applicants to have a defined research group and a robust training plan in place. The ACE Award is crucial for fostering the next generation of cancer researchers, ensuring they receive the necessary training and support to advance their careers. Interested applicants should note that the first due date for submissions is June 12, 2025, with an estimated award date of March 2, 2026, and no cost-sharing or matching requirements are necessary.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), specifically for early postdoctoral fellows in cancer research. This grant aims to enhance the pool of qualified individuals committed to careers in health-related research, particularly focusing on candidates from diverse backgrounds, including those underrepresented in the field. The program supports research training and requires applicants to identify a postdoctoral mentor and establish a comprehensive research and training plan. The estimated synopsis post date is April 1, 2025, with applications due by June 12, 2025, and the anticipated award date is March 1, 2026. For further details, applicants should refer to the NIH's official communications.
    Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This funding initiative aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly focusing on cancer health disparities, and allows applicants to apply during the late pre-doctoral or early postdoctoral stages without requiring preliminary data. The estimated synopsis post date is April 1, 2025, with applications due by June 12, 2025, and the anticipated award date is March 2, 2026. Interested applicants must identify a postdoctoral mentor and submit their applications through their respective institutions.
    Notice of Intent to Publish a Funding Opportunity Announcement for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award for Clinical Oncology (K12), aimed at supporting institutional research career development programs for clinical scientists in cancer research. This initiative emphasizes training for clinical scientists who aspire to lead independent clinical trials or contribute to existing trials, thereby enhancing the field of clinical cancer research. The NOFO is anticipated to be released in November 2024, with the first application deadline set for February 2025, and the estimated award date is January 5, 2026. Interested applicants are encouraged to begin developing collaborations and applications in advance, as there are no cost-sharing requirements associated with this grant opportunity.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Pathway to Independence Award (K99/R00 � Independent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the NCI Pathway to Independence Award (K99/R00), which includes an optional independent clinical trial component. This program aims to support talented postdoctoral researchers with up to six years of postdoctoral research training experience, facilitating their transition to independent tenure-track faculty positions while providing essential NCI research support to help launch their careers in cancer research. The estimated synopsis post date is November 1, 2024, with applications expected to close by February 14, 2025, and awards anticipated to be made by January 2, 2026. Interested applicants are encouraged to prepare their proposals in advance, as there are no cost-sharing requirements associated with this grant opportunity.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at supporting researchers transitioning from mentored, non-independent positions to their first independent tenure-track faculty roles in cancer research. This grant provides funding for up to three years, covering both salary and research development expenses, with the goal of enhancing the applicant's potential to secure independent NIH grants and fostering a diverse pool of capable scientists in the biomedical field. Eligible applicants include various institutions and organizations, particularly those serving underrepresented groups, and must adhere to detailed application guidelines. Interested parties can find more information and apply before the closing date of November 12, 2025, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.